Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yee

Showing results (601-610 of 709) with videos related to

Pageof 71
Sort By:
Annals of Surgical Oncology|October 23, 2025
Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal SurgeryElliott J Yee, Michael J Kirsch, Owen S Miller, et al.
Leukemia|February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activityH Eda, L Santo, D D Cirstea, et al.
Cancer|July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis BW Ray Kim, Rohit Loomba, Thomas Berg, et al.
Radiology|June 27, 2001
Analysis of initial CT findings after endovascular repair of abdominal aortic aneurysmR Sawhney, R K Kerlan, S D Wall, et al.
Hepatology (Baltimore, Md.)|May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virusLeland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Molecular Cancer Therapeutics|September 3, 2025
IL15/IL15Ra complex induces an anti-tumor immune response following radiation therapy only in the absence of Tregs and fails to expand progenitor TCF1+ CD8 T cellsMiles Piper, Chloe A Hodgson, Jacob Gadwa, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CTEric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
Journal of Medical Devices|February 6, 2015
Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical StudyAnand S Patel, Maythem Saeed, Erin J Yee, et al.
JACC. Heart Failure|September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and OutcomesOlivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
Pageof 71

Showing results (601-610 of 709) with videos related to

Sort By:
Pageof 71
Annals of Surgical Oncology|October 23, 2025
Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal SurgeryElliott J Yee, Michael J Kirsch, Owen S Miller, et al.
Leukemia|February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activityH Eda, L Santo, D D Cirstea, et al.
Cancer|July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis BW Ray Kim, Rohit Loomba, Thomas Berg, et al.
Radiology|June 27, 2001
Analysis of initial CT findings after endovascular repair of abdominal aortic aneurysmR Sawhney, R K Kerlan, S D Wall, et al.
Hepatology (Baltimore, Md.)|May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virusLeland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Molecular Cancer Therapeutics|September 3, 2025
IL15/IL15Ra complex induces an anti-tumor immune response following radiation therapy only in the absence of Tregs and fails to expand progenitor TCF1+ CD8 T cellsMiles Piper, Chloe A Hodgson, Jacob Gadwa, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CTEric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
Journal of Medical Devices|February 6, 2015
Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical StudyAnand S Patel, Maythem Saeed, Erin J Yee, et al.
JACC. Heart Failure|September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and OutcomesOlivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
Pageof 71